| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.00023 | 1 |